2017 ADA ANNUAL MEETING
Fairmont Copley Plaza, Boston, MA July 19-23, 2017
Program
Highlights
Page Schedule By Day Wednesday ...... 3 Thursday ...... 4 Friday ...... 6 Saturday ...... 9 Sunday...... 12
Agenda for First Executive Session ...... 13
CME Information and Financial Disclosures ...... 14
New Member Biosketches ...... 17
Board of Directors and Committees ...... 22
Award Recipients ...... 23
Acknowledgements ...... 24
In Memoriam ...... 25
ADA 137 T H ANNUA L MEETIN G 2 JUL Y 1 9 - 23, 2017
Program
WEDNESDAY, JULY 19, 2017
8:00 am – 12:00 pm BOARD OF DIRECTORS MEETING COPLEY ROOM 12:00 pm – 1:30 pm LUNCH FOR BOARD OF DIRECTORS AND GUESTS ST. JAMES ROOM 4:00 pm – 6:30 pm REGISTRATION OUTSIDE BALLROOM 6:00 pm – 8:00 pm OPENING RECEPTION (Dress: Casual) VENETIAN & OPAL ROOMS
ADA 137 T H ANNUA L MEETIN G 3 JUL Y 1 9 - 23, 2017
Program
THURSDAY, July 20, 2017
7:00 am – 12:30 pm REGISTRATION OUTSIDE BALLROOM
7:00 am – 8:30 am CONTINENTAL BREAKFAST FOR ADA MEMBERS BALLROOM FOYER
8:00 am – 10:00 am CONTINENTAL BREAKFAST FOR SPOUSES AND GUESTS ST. JAMES ROOM
7:30 am – 9:10 am FIRST EXECUTIVE SESSION GRAND BALLROOM
7:30 am Opening Remarks Robert Brodell, MD, Secretary-Treasurer
7:45 am Induction of New Members: Active, Associate, and International Honorary Members David Cohen, MD, President
8:15 am In Memoriam David Pariser, MD, Historian
8:25 am PRESIDENTIAL ADDRESS: Pivoting the ADA for the Future David Cohen, MD, President
8:55 am AAD Update Henry Lim, MD, AAD President
9:10 am – 10:30 am FIRST SCIENTIFIC SESSION GRAND BALLROOM
9:10 am – 10:30 am HEALTHCARE POLICY SESSION David Cohen, MD, Moderator
9:10 am Public Health and Dermatology - Preventing Skin Cancer Boris Lushniak, MD
9:35 am Q & A
9:50 am FDA and Dermatologic Public Health: From Medical Device Regulation to Drug Access – The Juxtaposed Role of Good Science and Good Regulation Markham Luke, MD, PhD
Markham Luke, MD, PhD, is the Director of the Division of Therapeutic Performance in the Office of Research and Standards at the FDA’s Office of Generic Drugs, which facilitates generic drug development through research and establishes standards to ensure therapeutic equivalence of new generic drugs. His interests include clinical study design, endpoints assessment (including patient-reported outcomes) for medical, surgical, and aesthetic products, and medical product development for rare diseases and special populations. From 2008 to 2016, he was Chief Medical Officer and Deputy Office Director in the Office of Device Evaluation (ODE), Center for Devices and Radiological Health. He was also Center Liaison for Emergency Preparedness and senior champion for regulation of UV indoor tanning devices. Born and raised in New York City, he majored in biochemistry at New York University, obtained his MD degree at Johns Hopkins University, and completed his PhD under Professor Donald S. Coffey in Pharmacology and Molecular Sciences. He was a dermatology resident at Washington University/Barnes Hospital, St. Louis, MO. He served as PHS Fellow and Clinical Associate for Dermatology at the National Cancer Institute, NIH, then as Medical Officer reviewer in the FDA Office of New Drugs. In 2001 he became Lead Medical Officer for dermatology at the FDA. He currently serves as an attending at Bethesda National Naval Medical Center (now Walter Reed Medical Center), instructor at the Uniformed Services University of the Health Sciences, and as a medical consultant for the NIH.
10:15 am Q & A
10:30 am – 10:55 am MEMBER BREAK BALLROOM FOYER
ADA 137 T H ANNUA L MEETIN G 4 JUL Y 1 9 - 23, 2017
Program
`THURSDAY, July 20, 2017 (continued)
(( 10:55 am – 12:20 pm SECOND SCIENTIFIC SESSION GRAND BALLROOM
10:55 am – 11:15 am YOUNG LEADERSHIP AWARD AND LECTURE Introduction by Amy Paller, MD
Atopic Dermatitis in Adults: Not Just Big Kids Jonathan Silverberg, MD, PhD, MPH
Jonathan I. Silverberg, MD, PhD, MPH, is Assistant Professor of Dermatology, Medical Social Sciences and Preventive Medicine at Northwestern University Feinberg School of Medicine in Chicago, IL. He is founder and Director of Northwestern Medicine’s Multidisciplinary Eczema Center and Director of the patch testing clinic at Northwestern Memorial Hospital. He received his doctorate in neuroimmunology, medical degree, and Master of Public Health degree in biostatistics and epidemiology from the State University of New York Downstate Medical Center in Brooklyn, where he also completed his internship in internal medicine. He did his residency training in dermatology at St. Luke’s-Roosevelt Hospital Center and Beth Israel Medical Center in New York, NY. Dr. Silverberg’s clinical subspecialty is inflammatory skin disease, particularly atopic and contact dermatitis. His research interests include dermato-epidemiology, health services research, patient-reported outcomes, comorbidities and burden of inflammatory skin disease and evidence-based dermatology. His publications include over 200 peer-reviewed articles, abstracts, books and book chapters. He has been a local and/or national principal investigator for numerous clinical trials for novel treatments in atopic dermatitis and other inflammatory disorders. He received the inaugural Rajka Award from the International Society for Atopic Dermatitis in 2014.
11:15 am Q & A
11:25 am – 12:20 pm MULTIDISCIPLINARY SESSION I: Challenging Cases in Medical Dermatology (ARS) Session Moderator: Lindy Peta Fox, MD Panel Speakers: Lindy Peta Fox, MD Jeffrey Callen, MD Mark Davis, MD Rosalie Elenitsas, MD
12:10 pm Q & A
12:20 pm Session Adjourns HURSDAY, July 20, 2017 ( AFTERNOON OPTIONAL ACTIVITY
12:40 pm SHARP!* Boston Red Sox Game at Fenway Park MEET IN BALLROOM FOYER AT 12:40 PM!
“Boston Red Sox vs Toronto Blue Jays”
Fenway Park is the oldest and one of America’s most beloved ballparks in Major League Baseball. We will depart the hotel lobby at 12:40 pm to walk in groups to the stadium. Alternatively, you may take a taxi or Uber. It is a five minute taxi ride, traffic permitting. The game begins at 1:35 pm and typically lasts about three hours.
ADA 137 T H ANNUA L MEETIN G 5 JUL Y 1 9 - 23, 2017
Program
FRIDAY, July 21, 2017
7:00 am – 1:30 pm REGISTRATION OUTSIDE BALLROOM
7:00 am – 8:00 am CONTINENTAL BREAKFAST FOR ADA MEMBERS BALLROOM FOYER
8:00 am – 10:00 am CONTINENTAL BREAKFAST FOR REGISTERED SPOUSES AND GUESTS ST. JAMES ROOM
7:05 am – 7:30 am Meet the New Members in Five Slides or Less GRAND BALLROOM Session Moderators: Desiree Ratner, MD, and Robert Brodell, MD Maryam Asgari, MD, MPH Ncoza Dlova, MBCHb, FCDerm, PhD Kristina Callis Duffin, MD Robert Sidbury, MD, MPH
7:30 am – 8:00 am SECOND EXECUTIVE SESSION GRAND BALLROOM Election of Officers and Directors David Cohen, MD, President
8:00 am – 10:45 am FIRST SCIENTIFIC SESSION
8:00 am – 8:55 am MULTIDISCIPLINARY SESSION II: Challenging Cases in Pediatric Dermatology (ARS) Session Moderator, Maria Garzon, MD Panel Speakers: Maria Garzon, MD Amy Paller, MD Ilona Frieden, MD Beth Drolet, MD
8:45 am Q & A
8:55 am – 9:15 am Early History of the ADA and Its Role in the Genesis of Other National Dermatologic Organizations David Pariser, MD, Historian
9:15 am – 9:45 am Best of the Derm Journals Session Moderator: Mary Maloney, MD
9:15 am Dirk Elston, MD (Journal of the American Academy of Dermatology)
9:25 am June Robinson, MD (JAMA DERM)
9:35 am Murad Alam, MD, MBA (Dermatologic Surgery)
9:45 am – 10:55 am Meet the New Members in Five Slides or Less Session Moderators: Wilma Bergfeld, MD; Pearon Lang, MD; Nicholas Soter, MD; and Daniel Siegel, MD
Lisa Beck, MD Lisa Donofrio, MD Lionel Bercovitch, MD Brigitte Dreno, MD Luca Borradori, MD Samuel Tzen-Yue Hwang, MD, PhD Francisco Bravo, MD Kishwer Nehal, MD Keith Choate, MD, Phd Avner Shemer, MD Jin Ho Chung, MD, PhD Andrea Zaenglein, MD
10:55 am – 11:15 am MEMBER BREAK
ADA 137 T H ANNUA L MEETIN G 6 JUL Y 1 9 - 23, 2017
Program
FRIDAY, July 21, 2017 (continued)
11:15 am – 1:20 pm FRIDAY, SECOND SCIENTIFIC SESSION GRAND BALLROOM
11:15 am – 1:20 pm HEALTH POLICY SESSION I: THE HOUSE OF MEDICINE Special Joint Session for ADA Members, Spouses and Guests
11:15 am Healthcare in the 21st Century Kathleen Sebelius, MPA Introduction by David Cohen, MD, President
Kathl een Sebelius is one of America’s foremost experts on national and global health issues, human services, and executive leadership. As CEO of Sebelius Resources LLC, she provides strategic advice to companies, inves tors, and non-profit organizations. Sebelius serves on the Board of Directors of Dermira, Grand Rounds, Ham pton Creek, Humacyte, the Kaiser Family Foundation, and Myovant Sciences. She co-chairs the Aspen Instit ute Health Strategy Group and serves on advisory boards for the Dole Institute of Politics, Solera Health, Out Leadership, and the Estée Lauder Foundation. From April 2009 through June 2014, Sebelius served in Presiident Barack Obama’s cabinet as the 21st Secretary of the Department of Health and Human Services, where, she worked to pa ss and implement the Affordable Care Act. At HHS, Sebelius managed 11 operating agencies, 90,000 employees in 50 countri es, and a $1 trillion budget. Forbes named Sebelius one of the 100 most powerful women in the world. Having served as Govern or of Kansas from 2003 to 2009, Sebelius is the only daughter of a governor to be elected governor in American history; her lat e father, John Gilligan, was Governor of Ohio. Time magazine named her one of America’s Top Five Governors. Previous elec ted offices include two terms as the Kansas Insurance Commissioner and four terms in the Kansas Legislature. Sebelius ear ned a Master of Public Administration degree from the University of Kansas and a Bachelor of Arts degree from Trinity Washington University. She is married to Gary Sebelius, a federal magistrate judge. They have two married sons, Ned and John, and two grandsons, George and Hugh.
11:40 am Q & A
11:55 am Changing Landscape of Compounding Regulations Natasha Pattanshetti, JD, MPH Introduction by Jeffrey Callen, MD
Natasha Pattanshetti is the Manager of Regulatory Policy with the American Academy of Dermatology Association in the Washington, DC office. Her work focuses on federal regulatory actions affecting the practice
of dermatology and advocacy in the interest of dermatologists and their patients. She is a graduate of the Case Western Reserve University School of Law and has a Master of Public Health from the Case Western Reserve University School of Medicine. She enjoys watching college football, especially her alma mater, the University of Michigan, and playing with her rescue dog Belle.
12::: 20 pm Q & A
ADA 137 T H ANNUA L MEETIN G 7 JUL Y 1 9 - 23, 2017
Program
FRIDAY, July 21, 2017 (continued)
12:35 pm From Institute of Medicine to National Academy of Medicine: GRAND BALLROOM Serving as a Trusted Advisor to Health and Medicine Victor Dzau, MD Introduction by Eugene Bauer, MD
Victor Joseph Dzau, MD, is President of the National Academy of Medicine. Born in Shanghai and reared in Hong Kong, he is an internationally acclaimed leader and scientist whose work has improved health care in the United States and globally. Under his direction, the National Academy of Medicine/Institute of Medicine advances research and improves health by providing objective, evidence-based guidance on critical issues. His foresight in translation of research into diagnostic methods, medicines, and creative solutions for human health issues is a great asset to the Academies and to the public at large. His own research laid the foundation for development of angiotensin-converting-enzyme (ACE) inhibitors used globally to treat high blood pressure and congestive heart failure. He pioneered gene therapy for vascular disease and was the first to introduce DNA decoy molecules to block transcription as gene therapy in humans. He is a member of the board of directors of the Singapore Health Services, a former member of the Advisory Committees to the Director of U.S. National Institutes of Health and the International Review Board of the Canadian Institute for Health Research. He chaired NIH’s Cardiovascular Disease Advisory Committee and is past chair of the Association of Academic Health Centers. In 2011, Dzau led a partnership among Duke Medicine, the World Economic Forum, and McKinsey & Co. to establish the International Partnership for Innovative Healthcare Delivery. Prior to becoming President of the National Academy of Medicine, Dr. Dzau served as Chancellor for Health Affairs and President & CEO of Duke University Medical Center. Earlier academic appointments include serving as the Hersey Professor of the Theory and Practice of Physic (Medicine) at Harvard Medical School, Chair of Medicine and Director of Research at Brigham and Women’s Hospital, and Arthur Bloomfield Professor and Chair of Medicine at Stanford University. He has received numerous awards including the Max Delbruck Medal from Humboldt University Charite and Max Planck Institute, the Gustav Nylin Medal from the Swedish Royal College of Medicine, the Polzer Prize from the European Academy of Sciences & Arts, the Ellis Island Medal of Honor, and the Distinguished Scientist Award of the American Heart Association. Dzau received his undergraduate and medical degrees from McGill University.
1:05 pm Q & A
1:20 pm Session Adjourns
AFTERNOON AT LEISURE
FRIDAY, July 21, 2017 (continued)
ADA 137 T H ANNUA L MEETIN G 8 JUL Y 1 9 - 23, 2017
Program
SATURDAY, JULY 22, 2017
7:00 am – 1:30 pm REGISTRATION OUTSIDE BALLROOM 7:00 am – 8:00 am FIRST 5-YEAR MEMBER BREAKFAST SESSION ST. JAMES ROOM Note: This session is limited to ADA members elected from 2013-2017 and Board members to discuss issues of common interest
7:00 am – 8:00 am CONTINENTAL BREAKFAST FOR ADA MEMBERS BALLROOM FOYER
8:00 am – 10:00 am CONTINENTAL BREAKFAST FOR REGISTERED SPOUSES AND GUESTS ST. JAMES ROOM
8:00 am – 10:25 am SATURDAY, FIRST SCIENTIFIC SESSION GRAND BALLROOM
8:00 am – 8:55 am MULTIDISCIPLINARY SESSION III: Challenging Cases in Cutaneous Oncology (ARS) Session Moderator, Desiree Ratner, MD Panel Speakers: Desiree Ratner, MD Chrysalyne Schmults, MD Allison Vidimos, MD Hensin Tsao, MD Martin Mihm, MD
8:45 am Q & A
8:55 am Resident Research Awardee Introduction by June Robinson, MD Namita Jain, MD, MPH Northwestern University Promoting Early Detection of Melanoma during the Mammography Experience
9:05 am Q & A
9:25 am – 10:45 am Meet the New Members in Five Slides or Less Session Moderators: Sewon Kang, MD; Suzanne Olbricht, MD; Ilona Frieden, MD
Christopher Bichakjian, MD Eckart Haneke, MD, PhD Ashish Bhatia, MD Mark Kaufmann, MD Oscar Rene Colegio, MD Douglas Parker, MD, DDS Kelly Cordoro, MD Bethanee Schlosser, MD, PhD Jonathan Dyer, MD Shinji Shimada, MD Scott Fosko, MD Alexander Stratigos, MD Kenneth Gordon, MD Vladimir Vasku, MD, CSC
10:45 am – 11:05 am MEMBER BREAK
ADA 137 T H ANNUA L MEETIN G 9 JUL Y 1 9 - 23, 2017
Program
SATURDAY, JULY 22, 2017 (continued)
11:05 am – 1:25 pm SATURDAY, SECOND SCIENTIFIC SESSION GRAND BALLROOM 11:05 am – 1:25 pm HEALTH POLICY SESSION II: THE HOUSE OF MEDICINE Session Moderator: Hensin Tsao, MD, PhD Special Joint Session for ADA Members, Spouses and Guests 11:05 am Harnessing the Internet of Healthy Things: How Connected Health Can Advance Dermatology Joseph Kvedar, MD Introduction by Hensin Tsao, MD, PhD
Joseph C. Kvedar, MD, Vice President, Connected Health, Partners HealthCare, is creating a new model of healthcare delivery, developing innovative strategies to move care from the hospital or doctor’s office into the day-to-day lives of patients. Under Dr. Kvedar’s leadership, Partners Connected Health is helping providers and patients better manage chronic conditions, maintain health and wellness, and improve adherence, engagement and clinical outcomes. He is also a board certified dermatologist and Associate Professor of Dermatology at Harvard Medical School.
Dr. Kvedar is the author of The Internet of Healthy Things describing how everyday objects will capture and use real-time biometric data to ultimately change behavior to improve health. Dr. Kvedar is internationally recognized for his leadership and vision in the field of connected health and has authored over 100 publications on the subject. His popular cHealth Blog provides his insights and vision for connected health. He contributes to a number of publications including the Journal of the American Academy of Dermatology, JAMA Dermatology and the Journal of Investigative Dermatology. Dr. Kvedar is a past Chair of the American Academy of Dermatology (AAD) Task Force on Telemedicine.
11:35 am Drug/Device Discovery/Innovation Transfer - From Disclosure to Patent to License Rox Anderson, MD, PhD
12:05 pm Development of Novel Drugs for Neoplastic Diseases Michael Kauffman, MD, PhD
Michael G. Kauffman, MD, PhD, co-founded Karyopharm with Dr. Sharon Shacham in 2008 and has served as President and Chief Executive Officer since January 2011, as Chief Medical Officer since December 2012, and as
a director since 2008. Prior to joining Karyopharm, he was Chief Medical Officer of Onyx Pharmaceuticals Inc., after it acquired Proteolix Inc., where he had been Chief Medical Officer since 2008. At Proteolix, Dr. Kauffman led the development of Kyprolis (carfilzomib), a novel proteasome inhibitor approved for refractory myeloma by the FDA in July 2012. Prior to joining Onyx Pharmaceuticals, Dr. Kauffman was an operating partner at Bessemer Venture Partners, where he led investments in biotechnology companies and served as President and Chief Executive Officer of Epix Pharmaceuticals, Inc., a biopharmaceutical company that underwent liquidation proceedings in 2009. He led the merger of P redix Pharmaceuticals, a private biopharmaceutical company focused on G protein-coupled receptors (GPCR)s, and Epix Pharmaceuticals, where he oversaw the discovery and development of four new clinical candidates and led collaboration transactions with Amgen and GlaxoSmithKline. Dr. Kauffman served as Vice President, Clinical, at Millennium Pharmaceuticals, Inc., where he led the Velcade development program. Dr. Kauffman held a number of senior positions at Millennium Predictive Medicine, Inc., where he led the discovery and development of novel molecular diagnostics for major cancers (including melanoma) and led transactions with Becton-Dickenson and Bristol Myers Squibb. Early in his career, Dr. Kauffman led the clinical development of anti- CD40L antibodies in autoimmune and inflammatory diseases at Biogen Idec, Inc. and acted as the main medical advisor to the Biogen business development group. Dr. Kauffman currently serves on the board of directors and compensation committee of Verastem, Inc., a public biopharmaceutical company, and on the board of directors and the compensation committee of Metamark Genetics, Inc., a private molecular diagnostics company. Dr. Kauffman received his B.A. in Biochemistry from Amherst College, his M.D. and PhD from Johns Hopkins Medical School, and trained in internal medicine and rheumatology at Beth Israel (now Beth Israel Deaconess Medical Center) and Massachusetts General Hospitals. He is board certified in internal medicine.
ADA 137 T H ANNUA L MEETIN G 10 JUL Y 1 9 - 23, 2017
Program
SATURDAY, JULY 22, 2017 (continued)
12:35 pm Drug Development: Target Identification Through Commercialization GRAND BALLROOM Eugene Bauer, MD
1:00 pm Q & A 1:25 pm Session Adjourns
AFTERNOON OPTIONAL ACTIVITY (Sold out)
ISABELLA STEWART GARDNER MUSEUM (Pre Registration and Fee Required) Bus departs promptly at 2:45 SHARP from Hotel Lobby
The Isabella Stewart Gardner Museum or Fenway Court, as the museum was known during Isabella Stewart Gardner's lifetime, is a museum in the Fenway-Kenmore neighborhood of Boston, Massachusetts, located within walking distance of the Museum of Fine Arts and near the Back Bay Fens. The museum houses an art collection of world importance, including significant examples of European, Asian, and American art, from paintings and sculpture to tapestries and decorative arts. In 1990, thirteen of the museum's works were stolen; the high-profile crime remains unsolved and the artwork's location is still unknown.
EVENING ACTIVITIES FOR ALL MEMBERS AND REGISTERED SPOUSES/GUESTS
Photo Session for New Members, Spouses and Board of Directors (Attendance required)
5:00 pm SHARP! Location: Forum Room
President’s Cocktail Reception & Dinner Dance Attire: Black Tie
6:00 pm – 7:00 pm President’s Cocktail Reception BALLROOM FOYER 7:00 pm President’s Dinner / Dance GRAND BALLROOM
ADA 137 T H ANNUA L MEETIN G 11 JUL Y 1 9 - 23, 2017
Program
SUNDAY, JULY 23, 2017
7:30 am – 10:30 am REGISTRATION OUTSIDE BALLROOM
7:00 am – 7:30 am BOARD OF DIRECTORS MEETING COPLEY ROOM
7:30 am – 9:30 am FAREWELL BREAKFAST BUFFET VENETIAN ROOM (ADA MEMBERS, SPOUSES AND GUESTS)
8:00 am – 9:50 am SUNDAY SCIENTIFIC SESSION GRAND BALLROOM
8:00 am – 9:50 am MULTIDISCIPLINARY SESSION IV: Challenging Cases in Skin of Color (ARS) Session Moderator, Amy McMichael, MD
8:00 am Panel Speakers: Amy McMichael, MD Valerie Callender, MD Andrew Alexis, MD Pearl Grimes, MD Susan Taylor, MD
8:40 am Q & A
8:50 am – 10:00 am MY WOW MOMENT - 6 Minute Pearls Session Moderator, Kenneth Tomecki, MD
Speakers: Anthony Benedetto, DO Christopher Bunker, MD Lawrence Eichenfield, MD Dirk Elston, MD Dee Anna Glaser, MD Alexa Kimball, MD David Mehregan, MD Alain Rook, MD Bruce Thiers, MD
10:00 am – 10:15 am THIRD EXECUTIVE SESSION (ADA MEMBERS) Robert Brodell, MD, Secretary-Treasurer
Announcement of 2018 Nominees
10:15 am MEETING CONCLUDES
ADA 137 T H ANNUA L MEETIN G 12 JUL Y 1 9 - 23, 2017
Program
FAIRMONT, COPLEY PLAZA, BOSTON, MASSACHUSETTS Thursday, July 20, 2017 8:00 AM - First Executive Session
Call Meeting to Order Establishment of a Quorum Report of the Board of Directors Report of the Secretary-Treasurer Report of the Historian Report of the Nominating Committee Report of the Committee on Membership
Introduction of New Members
Active Membership International Membership Maryam Asgari, MD, MPH Boston, MA Luca Borradori, MD Bern, Switzerland Lisa A. Beck, MD Rochester, NY Francisco Bravo, MD Lima, Peru Lionel Bercovitch, MD Providence, RI Jin Ho Chung, MD, PhD Seoul, Korea Ashish Bhatia, MD Aurora, IL Ncoza Dlova, MBChB, FCDerm,PhD Durban, South Africa Christopher Bichakjian, MD Ann Arbor, MI Brigitte Dreno, MD, PhD Nantes, France Keith Choate, MD, PhD Chicago, IL Eckart Haneke, MD, PhD Erlangen, Germany Oscar Rene Colegio, MD, PhD East Haven, CT Avner Shemer, MD Netanya, Israel Kelly Cordoro, MD San Francisco, CA Shinji Shimada, MD Yamanashi, Japan Lisa Donofrio, MD Los Angeles, CA Alexander Stratigos, MD Athens, Greece Kristina Callis Duffin, MD, MS Salt Lake City, UT Vladimir Vasku, MD, C.S.c Brno, Switzerland Jonathan Dyer, MD Columbia, MO Scott W. Fosko, MD Jacksonville, FL Associate Membership Kenneth Gordon, MD Milwaukee, WI Douglas Parker, MD, DDS Atlanta, GA Samuel Hwang, MD, PhD Sacramento, CA Mark G. Kaufmann, MD New York, NY Kishwer Nehal, MD New York, NY Bethanee Schlosser, MD, PhD Chicago, IL Robert Sidbury, MD, MPH Seattle, WA Andrea Zaenglein, MD Hershey, PA
Unfinished Business
New Business
Adjournment
ADA 137 T H ANNUA L MEETIN G 13 JUL Y 1 9 - 23, 2017
CME Disclosures
AMERICAN DERMATOLOGICAL ASSOCIATION
Target Audience This program is designed for dermatologists who are members of the American Dermatological Association.
Accreditation This activity has been planned and implemented in accordance with the E ssential Areas and policies of the Accreditation Council for Continuing Medical E ducation through the joint providership of E astern Virginia Medical S chool and the American Dermatological Association. E astern Virginia Medical S chool is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation E astern Virginia Medical S chool designates this live activity for a maximum of 12.75 AMA PRA Category1 Credits™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.
Learning Objectives 1. Increase knowledge & competence of members through lectures and interaction. 2. Improve patient care through discussion and debates on current and controversial treatment options. 3. Analyze and critique latest research of members. 4. Utilize leader memberships to develop “think tank” analyses of various disorders and treatments.
Disclosure of Significant Relationships with Relevant Commercial Companies/Organizations
E astern Virginia Medical S chool endorses the S tandards for Commercial S upport of the Accreditation Council for Continuing Medical E ducation and the Guidelines of the Association of American Medical Colleges that the sponsors of continuing medical education activities and the speakers at these activities disclose relevant relationships with commercial companies whose products or services are discussed in educational presentations.
For sponsors, relevant relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution. For speakers, relevant relationships include receiving from a commercial company research grants, consultancies, honoraria and travel, other benefits, or having a self-managed equity interest in a company.
The following planning committee members or presenters have disclosed that they do not have any relevant relationships with commercial companies: Murad Alam, MD, MBA; Andrew Alexis, MD; Wilma Bergfeld, MD; Christopher Bunker, MD;J effrey Callen, MD; Mark Davis, MD; Victor
ADA 137 T H ANNUA L MEETIN G 14 JUL Y 1 9 - 23, 2017
CME Disclosures
Dzau, MD; Lawrence Eichenfeld, MD; Dirk Elston, MD; Lindy Peta Fox, MD; Maria Garzon, MD; Namita Jain, MD; Sewon Kang, MD; Alexa Kimball, MD; Pearon Lang, MD; Henry Lim, MD; Markham Luke, MD, PhD; Boris Lushniak, MD; Mary Maloney, MD; David Mehregan, MD; Suzanne Olbricht, MD; Amy Paller, MD; David Pariser, MD; Natasha Pattenshetti, JD, MPH; Desiree Ratner, MD; June Robinson, MD; Alain Rook, MD; Chrysalyne Schmults, MD; Katheleen Sebelius, MPA; Daniel Siegel, MD; Nicholas Soter, MD; Bruce Thiers, MD; Kenneth Tomecki, MD; and Hensin Tsao, MD.
The following planning committee members or presenters have disclosed that they do have relevant relationships with commercial companies
R. Rox Anderson, MD, PhD Consultant for Blossom Innovations, Cytrellis Biosystems, Follica, MOE Medical Device, NextGen Jane, R2 Dermatology; SevenOaks Biosystems; Sofregan Medical; STGS Innovations; and Strata Skin Sciences..
Eugene Bauer, MD Major Stock Shareholder for Dermira, Inc./Founder & Chief Medical Officer.
Anthony Benedetto, DO Grant/Research Support from Allergan, Inc.; Revance; and Stratpharma. Consultant for Excaliard Pharmaceuticals, Inc.; Johnson & Johnson Consumer Products, Co; Merz Pharmaceuticals, LLC; Revance; Shire; and Stratpharma. Speakers List for Allergan, Inc.; DUSA Pharmaceuticals, Inc; Liposonix; Lumenis; Merz Pharmaceuticals; Revance; and Stratpharma. Stockholder for Allergan, Inc.; Astellas Pharma, US, Inc.; BioDelivery Systems, Inc.; Bristol-Myers Squibb; Elan; and Sanofi-Aventis. Advisory Board member of Castle Biosciences, Inc.
Robert Brodell, MD Consultant for Galderma Laboratories, LP; Hoffmann-La Roche; and Novartis. Radiation Therapy Advisory Board member. Research support for Genentech; Janssen Pharmaceuticals; Galderma; and Novartis.
Valerie Callender, MD Grants/Research Support from Allergan and Galderma. Consultant for Allergan. Speakers List for Allergan.
David Cohen, MD Consultant for Medimetriks, Ferndale, FIDE; Erchonia; and SkinFix. Other Financial/Material Support from Dermira (Board of Directors, stock and option holder); Medimetrik options holder.
Beth Drolet, MD Grant/Research Support from Pierre Fabre.
ADA 137 T H ANNUA L MEETIN G 15 JUL Y 1 9 - 23, 2017
CME Disclosures
Rosalie Elenitsas, MD Consultant for Myriad Genetics.
Ilona Frieden, MD Consultant for Pierre Fabre.
Dee Anna Glaser, MD Grant/Research Support from Allergan, Dermira, Galderma, and Brickell. Consultant for Allergan, Dermira, and Galderma. Speakers List for Allergan and Galderma.
Pearl Grimes, MD Grant/Research Support from L’Oreal, Cassiopea, Galderma, Suneva, Allergan, and Alphaeon. Consultant for Proctor and Gamble. Speakers List and on Advisory Board for Clarify Medical.
Michael Kauffman, MD, PhD Major stock shareholder for Karyopharm Therapeutics, Inc. – CEO and Lead Director for Verastem, Inc.
Joseph Kvedar, MD Grant/research Support from Raiing Medical, Daiichi Sankyo, Astellas, RSMEd, Prima Temp, BD Technologies, Samsung, Hitachi, Philips, and Amgen. Consultant for Puretech Ventures and Qualcomm Life. Major stock shareholder for MD Revolution and Claritas Mind Sciences.
Amy McMichael, MD Research/Grant Support from Allergan, Cassiopea, Proctor & Gamble, and Samumed. Consultant for Aclaris, Allergan, Cassiopea, Covance, eResearch Technology, Inc., Galderma, Guthey Renker, Incyte, Johnson& Johnson, Keranetics, Merck & Co., Inc., Merz Pharmaceuticals, Pfizer, Proctor & Gamble, and Samumed. Other financial/material support from Informa Healthcare and Up-To-Date.
Martin Mihm, MD Consultant for Alnylam, Novartis, and MelaSciences. On the Advisory Board for BioCoz and Caliber ID.
Jonathan Silverberg, MD, PhD, MPH Consultant for Abbvie, Anacor, Eli Lilly, GlaxoSmith Kline, Medimmune, Pfizer, Regeneron-Sanofi, and Realm. Speakers List for Regeneron-Sanofi.
Susan Taylor, MD Grant/Research Support for Teoxane, Croma, Evolus, Galderma, Johnson & Johnson, and Aclaris. Consultant for Johnson & Johnson, Aclaris, and Beiersdorf.
Allison Vidimos, MD Grant/Research Support from Genentech.
All potential conflicts of interest have been resolved.
ADA 137 T H ANNUA L MEETIN G 16 JUL Y 1 9 - 23, 2017 New Member
Biosketches
Maryam Asgari, MD, MPH* Ashish Bhatia, MD* City of Residency: Chestnut Hill, MA City of Residency: Aurora, IL Medical School: Yale University School of Medicine Medical School: Northeastern Ohio University, Internship: Beth Israel Deaconess Medical Center, Boston, College of Medicine MA Internship: Northeastern Ohio University, College of Residency: University of Washington School of Medicine Medicine Affiliate Hospitals Fellowship: University of Texas Southwestern Medical Residency: Medical College of Virginia Hospitals/ School Virginia Commonwealth University Current Appointment: Associate Professor, Department of Fellowship: SkinCare Physicians of Chestnut Hill, Dermatology at Massachusetts General Hospital and Chestnut Hill, MA Department of Population Medicine at Harvard Medical Current Appointment: Associate Professor of Clinical School Dermatology Northwestern University, Chairman Area of Interest: Mohs sugery, Cutaneous Oncology and Department of Dermatology, DuPage Medical Group Melanoma, Director, High Risk Skin Cancer Clinic, Medical Director for Dermatologic Research Department Massachusetts General Hospital of Clinical Research, DuPage Medical Group Co-Director of Dermatologic, Laser & Cosmetic Surgery Area of Interest: Autologous Tissue Regenerat ion, Dermatologic Surgery, Laser Physics & Applications, Lisa Beck, MD* Clinical Research City of Residency: Rochester, NY Medical School: SUNY Stony Brook Internship: PGY1 and PGY2 - Strong Memorial Hospital- University of Rochester Medical Cener Christopher Bichakjian, MD* Residency: Dermatology Residency-Duke University City of Residency: Ann Arbor, MI Medical Center Medical School: Radboud University, Nijmegen, The Fellowship: Immunology Research Fellowship, Johns Netherlands Hopkins Medical Center Internship: Henry Ford Hospital Current Appointment: Tenured Professor of Residency: University of Michigan Dermatology, Medicine and Pathology at URMC Fellowship: Mohs Sugery and Cutaneous Oncology, Area of Interest: Allergic skin disease (atopic dermatitis, University of Michigan mastocytosis, eosinophilic skin disorders and chronic Current Appointment: Clinical Professor of Dermatology; urticaria) Chief, Division of Cutaneous Surgery and Oncology; Director, Multi disciplinary Melanoma and Merkel Cell Carcinoma Programs, University of Michigan Area of Interest: Merkel Cell Carcinoma, Melanoma, Lionel Bercovitch, MD* Cutaeous Oncology, Mohs Surgery City of Residency: Providence, RI Medical School: University of Manitoba Internship: Manitoba Health Science Centre Residency: Medicine-Massachusetts General Hospital, Dermatology - Brown University Affiliated Hospitals Current Appointment: Professor Of Dermatology, Warren Alpert Medical School of Brown University, Director of Pediatric Dermatology, Hasbro Children's Hosptial and Brown Dermatology, Director of Brown Contact Dermatitus Center; Medical Director, PXE International Area of Interest: Pediatric Dermatology, Ethical Issues in Dermatology, Pseudoxanthoma Elasticum
ADA 137 T H ANNUA L MEETIN G 17 JUL Y 1 9 - 23, 2017 New Member
Biosketches
Luca Borradori, MD** Jin Ho Chung, MD, PhD** City of Residency: Seoul, Korea City of Residency: Berne, Switzerland Medical School: Seoul National University College of Medical School: Medical Faculty University of Berne, Medicine, Seoul, Korea Switzerland Internship: Seoul National University Hospital, Seoul, Internship: Department of Internal Medicine, Outpatient Korea Clinic, Berne University Hospital Residency: Department of Dermatology, Seoul National Residency: Department of Dermatology, University University Hospital, Seoul, Korea Hospital Hospital Geneva and Lausanne, Switzerland and Fellowship: Department of Dermatology, Seoul National Hopital Saint Louis University, Paris VII, France University Hospital, Seoul, Korea-Department of Fellowship: Postdoctoral Fellow, Dermatology Branch, Dermatology, University of Michigan NCI, NIH, Bethesda, MD, USA, Postdoctoral Fellow, Dept. Current Appointment: of Cell Biology, The Netherlands Cancer Institute, The Professor and Chairman, Department of Dermatology, Netherlands Seoul National University College of Medicine, Seoul, Current Appointment: Chairman and Director, full Korea professor, Dept. of Dermatology, University Hospital, Bern, Switzerland Area of Interest: Clinical subjects: autoimmune bullous disease, connective tissue diseases, neutrophilic disease, Oscar Rene Colegio, MD, PhD* general dermatology, Research subjects: epidermal basement City of Residency: East Haven, CT membrane, hemidesmosomes, cytoarchitecture, Medical School: Yale University School of Medicine spectraplakins, intermediate filaments, autoimmune bullous Internship: Internal Medicine, Yale-New Haven Hospital diseases Residency: Dermatology, Yale-New Haven Hospital Current Appointment: Associate Professor of Dermatology, Pathology and Francisco Gerardo Bravo, MD** Surgery, Director, Yale Transplant Dermatology Clinic, Yale University School of Medicine City of Residency: Lima, Peru Area of Interest: Skin cancer, skin diseases associated with Medical School: Universidad Peruana Cayetano Heredia, transplantation, tumor immunology. Lima, Peru Area of Interest: Photobiology, Photomedicine skin aging Internship: Southern Illinois University, Springfield, and photoaging, utoimmune bullous diseases, rheumatic skin Illinois diseases and other Inflammatory and autoimmune skin Residency: Internal Medicine at Southern Illinois diseases, systemic therapy, laser and procedures), University , Springfield , Illinois; Dermatology at collaborative research, public speaking and teaching, University of California Davis , Sacramento, California volunteerism and patientadvocacy Fellowship: Dermatopathology at New York University Current Appointment: Associate Professor Dermatology and Pathology, Universidad Peruana Cayetano Heredia, Lima, Peru Kelly Cordoro, MD* Area of Interest: Dermatopathology, Tropical Infectious City of Residency: San Francisco, CA Diseases, Acral Melanoma Medical School: Pennsylvania State University College of Medicine Internship: Internal Medicine, University of Virginia Keith Choate, MD, PhD* Residency: Dermatology, University of Virginia Fellowship: Pediatric Dermatology, University of City of Residency: Wallingford, CT California, San Francisco Medical School: Yale University School of Medicine Current Appointment: Associate Professor of Internship: Internal Medicine, Yale-New Haven Hospital Dermatology and Pediatrics, University of California, Residency: Dermatology, Yale-New Haven Hospital San Francisco and UCSF Benioff Children’s Hospital, Current Appointment: Assoicate Professor of San Francisco; Assistant Chief, Division of Pediatric Dermatology, Genetics and Pathology, Director of Dermatology and Pediatric Dermatology Fellowship Research, Dermatology, Associate Director Medical Director Scientist Training Program Area of Interest: Pediatric Dermatology (psoriasis and Area of Interest: Genodermatoses, medical dermatology other inflammatory and autoimmune skin diseases, systemic
therapy, lasser and procedures), collaborative reearch, public speaking and teaching, volunteerism and patient advocacy.
ADA 137 T H ANNUA L MEETIN G 18 JUL Y 1 9 - 23, 2017 New Member
Biosketches
Ncoza Dlova, MBChB, FCDerm, PhD** Kristina Callis Duffin, MD* City of Residency: Durban, South Africa City of Residency: Salt Lake City, UT Medical School: Nelson R. Mandela School of Medine, Medical School: University of Washington School of University of KwaZulu-Natal, Durban, South Africa Medicine Internship: Livingstone Hospital, Port Elizabeth, South Internship: Maine Medical Center Africa Residency: Internal Medicine- Maine Medical Center, Residency: Dermatology Department , Nelson R. Mandela Dermatology- University of Utah School of Medicine, University of KwaZulu-Natal, Durban, Current Appointment: Associate Professor, Dermatology, South Africa University of Utah Fellowship: PhD, Dermatology, Nelson R. Mandela School Area of Interest: Psoriasis of Medicine, University of KwaZulu-Natal, Durban, South
Africa Current Appointment: Chief Specialist, Associate Jonathan A. Dyer, MD* Professor Head of Department-President’s African City of Residency: Columbia, MO Women’s Dermatology Society Medical School: University of Missouri Area of Interest: Ethnic Skin and Hair, HIV and Skin, Internship: Internal Medicine - University of Missouri. Atopic Eczema, Hyperpigmentation Disorders Residency: Dermatology-University of Missouri Fellowship: Pediatric Dermatology-Northwestern University Lisa Donofrio, MD* Current Appointment: Associate Professor of City of Residency: New Orleans, LA Dermatology and Child Health – University of Missouri Medical School: Tulane University Area of Interest: Genodermatoses, Epigenetics, Internship: Internal Medicine, Tulane University Mosaicism, Telemedicine, Pediatric Dermatology, Residency: Tulane University Dermatologic Education, Cutaneous Loxoscelism, Atopic Current Appointment: Associate Clinical Professor, Dermatitis, Inflammatory skin disease, Infectious disease, Dermatology, Yale University and Assistant Clinical History of Dermatology, Physician Professor, Dermatology, Tulane University Burnout Area of Interest: Cosmetic Dermatologic Surgery Dermatology
Brigitte Dréno, MD, PhD** Scott W. Fosko, MD* City of Residency: Nantes, France City of Residency: Atlantic Beach, FL Medical School: Nantes University School of Medicine Medical School: University of Maryland Internship: University Hospital of Rennes France Internship: Internal Medicine, University of Virginia Residency: Rennes College of Medicine of France Residency: Internal Medicine- University of Virginia, Current Appointment: Professor and Head of Dermatology- Yale University Dermatology & Skin Cancer Department, Director: GMP Fellowship: University of Pennsylvania, Mohs Sugery and Unit of Cell and Gene Therapy, Clinical Investigative Dermatologic Surgery Center, INSERM (basic research team in skin, at the Current Appointment: Nantes Univerisity Hospital Hotel Dieu and the Nantes Chair, Department of Dermatology, Mayo Clinic Florida University School of Medicine, Nantes, France Area of Interest: Multidisciplinary care of high risk skin Area of Interest: Skin Cancer, immunotherapy of cancers, hedgehog inhibitor therapy for basal cell melanoma, acne and related diseases. carcinoma, imiquimod for novel oncologic uses, and quality improvement in health care delivery
ADA 137 T H ANNUA L MEETIN G 19 JUL Y 1 9 - 23, 2017 New Member
Biosketches
Kenneth B. Gordon, MD* City of Residency: Northbrook, IL Kishwer Nehal, MD* Medical School: Columbia University, College of City of Residency: Weehawken, NJ Physicians and Surgeons Medical School: Boston University School of Medicine Internship: Beth Israel Hospital, Boston, MA Internship: Beth Israel Hospital, Boston, MA Residency: Northwestern University Residency: New York University Medical Center Current Appointment: Professor and Chair, Department Fellowship: New York University Medical Center of Dermatology, Medical College of Wisconsin Current Appointment: Director of Mohs and Area of Interest: Psoriasis, severe inflammatory skin Dermatologic Surgery, Attending Physician, Memorial Disease Sloan-Kettering Cancer Center, New York, NY Professor of Dermatology Weill Medical College of Cornell University, New York, NY Eckart Haneke, MD, PhD** Area of Interest: Cutaneous Oncology, Dermatologic City of Residency: Freiburg, Germany Surgery, Mohs Micrographic Surgery, Reflectance Confocal Medical School: Univ Berne, Switzerland Microscopy, Lentigo Maligna Melanoma Internship: Univ Hospitals, Halle/Saale, Germany Residency: Dept Dermatol, Univ Halle/Saale Fellowship: Dept Dermatol, Univ Halle/Saale and Dept Douglas C. Parker, MD, DDS*** Dermatol, Univ Erlangen City of Residency: Atlanta, GA Current Appointment: Dept Dermatol Inselspital, Univ Medical School: Emory University School of Medicine Bern, Switzerland , Dept Dermatol, Univ Hospital, Gent, Residency: Anatomic Pathology, Emory University Belgium , Centro de Dermatología Inst CUF, Porto, Portugal Fellowship: Surgical Pathology & Dermatopathology, Dermatol Ctr Dermaticum, Freiburg, Germany Emory University Area of Interest: Nail diseases including surgery and Current Appointment: Associate Professor of Pathology onychopathology, dermatological surgery, and Dermatology, Emory University School of Medicine; dermatopathology, diseases of the oral mucosa Chief of Dermatopathology Emory University Hospital Area of Interest: Dermatopathology, Melanocytic tumors, Sam Tzen-yue Hwang, MD, PhD* Medical Education. City of Residency: Sacremento, CA Medical School: Harvard Medical School Internship: Brigham & Women Hospital Bethanee Schlosser, MD, PhD* Residency: University California San Franscisco City of Residency: Chicago, IL Fellowship: University of California, San Franscico, CA Medical School: Pennsylvania State University College Current Appointment: of Medicine Professor & Chair of Dermatology, University California Internship: Mayo Clinic, Jacksonville, FL Davis at Sacremento Residency: Emory University School of Medicine Area of Interest: Psoriasis, CTCL Current Appointment: Associate Professor, Department of Dermatology and Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Mark D. Kaufmann, MD* Medicine. City of Residency: New York, NY Area of Interest: Women’s skin health: vulvar Medical School: NYU School of Medicine dermatology, skin diseases in pregnancy, acne, rosacea Internship: Hospital of the University of Pennsylvania Area of Interest: Dermatomycology Residency: Albert Einstein College of Medicine Current Appointment: Associate Clinical Professor, Department of Dermatology, Icahn School of Medicine at Mount Sinai Area of Interest: General Dermatology, Payment Policy
ADA 137 T H ANNUA L MEETIN G 20 JUL Y 1 9 - 23, 2017 New Member
Biosketches
Avner Shemer, MD** Alexander J. Stratigos, MD** City of Residency: Netanya, Israel City of Residency: Athens, Greece Medical School: Sackler School Medicine, Tel-Aviv Medical School: National and Kapodistrian University of University, Israel Athens Internship: Chaim Sheba Medical Center, Ramat Gan, Internship: Medical Services, Massachusetts General Israel Hospital, Harvard Medical School Residency: Dermatology and Venerology, Rambam Residency: Department of Dermatology, Harvard Medical Medical Center, Haifa, Israel School Fellowship: Mycological Institute, Laboratory Institute Fellowship: Lasers and photobiology, MGH/Wellman of Dermatology, Guy's Hospital, London Laboratories of Photomedicine & Beth Israel Deaconess Current Appointment: Senior Physician, Department of Medical Center, Harvard Medical School Dermatology and Venereology, Chaim Sheba, Medical Current Appointment: Professor of Dermatology, Center, Tel Hashomer Venereology, National and Kapodistrian University of Athens School of Medicine, Andreas Sygros Hospital,
Athens, Greece Shinji Shimada, MD, PhD** Area of Interest: Melanoma, Cutaneous Oncology, City of Residency: Chuo Yamanashi, Japan Photodermatology, Lasers Medical School: University of Tokyo Internship: University of Tokyo Residency: University of Tokyo Vladimir Vasku, MD, CSc** Current Appointment: President, University of City of Residency: Brno, Switzerland Yamanashi, President , Japanese Dermatological Association Medical School: Masaryk University, Brno, Czech Republic Internship: In curriculum of medical student,
preventive medicine. Medical Faculty Masaryk University in Robert Sidbury, MD, MPH* Brno City of Residency: Seattle, WA Residency: Dermatovenereological Clinic, Medical Faculty Medical School: Duke University School of Medicine Masaryk University in Breno Internship: University of California, San Francisco Fellowship: Department of Dermatology Cleveland Clinic Residency: Oregon Health Sciences University Foundation Fellowship: Northwestern University-Pediatric Current Appointment: Professor & Chair of Dermatology & Harvard University-Pediatric Health Dermatovenereological Clinic in Brno, Scientific Secretary- Sciences Research Czech Academy of DV Current Appointment: Professor, Department of Area of Interest: CTCL, Psoriasis, Phototherapy, Pediatrics, Seattle Children's Hospital and Chief, Division Polygenic Skin Diseases of Dermatology, University of Washington School of Medicine Area of Interest: Pediatric Dermatology Andrea Zaenglein, MD* City of Residency: Hershey, PA Medical School: Pennsylvania State University College of Medicine Internship: George Washington University Residency: MCP Hahnemann University Fellowship: New York University Medical Center Current Appointment: Professor of Dermatology and Pediatrics, Penn State College of Medicine/Hershey Medical Center Area of Interest: Pediatric Dermatology, Acne
ADA 137 T H ANNUA L MEETIN G 21 JUL Y 1 9 - 23, 2017 Board of Directors &
Committee Membe rs
BOARD OF DIRECTORS ETHICAL ISSUES COMMITTEE David Cohen, MD, ADA, President Harold Brody, MD, Chair Antoinette Hood, MD, Past President William James, MD Eugene Bauer, MD, President-Elect Jack Resneck, Jr., MD Brian Berman, MD, Vice President Robert Brodell, MD, Ex-Officio Robert Brodell, MD, Secretary-Treasurer David Pariser, MD, Historian PROGRAM COMMITTEE Diane Baker, MD, Director Janet Fairley, MD, Director Desiree Ratner, MD, Program Chair Lawrence Eichenfield, MD, Director Hensin Tsao, MD Kenneth Tomecki, MD, Director Jeffrey Callen, MD Karen Burke, MD, PhD, First Five Year Member, Director Amy Paller, MD David Cohen, MD, President Robert Brodell, MD, Ex-Officio MEMBERSHIP COMMITTEE
Nicholas Soter, MD, Secretary MEETING SITE COMMITTEE Ilona Frieden,MD Valerie Callender, MD Anthony Benedetto, DO, Chair Daniel Siegel, MD Mark Pittelkow, MD Pearl Grimes, MD Sabra Sullivan, MD Daniela Kroshinsky, MD Jerry Shapiro, MD Robert Brodell, MD, Ex Officio Robert Brodell, MD, Ex-Officio
HONORARY MEMBERSHIP COMMITTEE AUDITING COMMITTEE Wilma Bergfeld, MD, Chair Larry Millikan, MD, Chair Lawrence Gibson,MD Barbara Mathes, MD Pearon Lang,MD Thomas Helm, MD Suzanne Olbricht, MD Sewon Kang, MD INVESTMENT COMMITTEE Robert Brodell, MD, Ex-Officio David Pariser, MD NOMINATING COMMITTEE Eugene Bauer, MD Brian Berman, MD, PhD Kathryn Schwarzenberger, MD, Chair Rex Amonette, MD Suzanne Connolly, MD David Bickers, MD Craig Elmets, MD Janet Hickman, MD Cynthia Yag Howard, MD Marianne O'Donoghue, MD ENDOWMENT COMMITTEE Antoinette Hood, MD, Ex-Officio Robert Brodell, MD, Ex-Officio Ralph Daniel, MD, Chair Rex Amonette, MD EDUCATION COMMITTEE Kenneth Tomecki, MD David Pariser, MD Timothy Berger, MD, Chair Victor Marks, MD Harvey Lui, MD Abby Van Voorhees, MD David Cohen, MD, Ex Officio
ADA 137 T H ANNUA L MEETIN G 22 JUL Y 1 9 - 23, 2017 Award Recipients
YOUNG LEADERSHIP AWARD RECIPIENT
Jonathan I Silverberg, MD, PhD, MPH
Atopic dermatitis (AD) is an inflammatory skin disorder that commonly affects adults. There are a number of key differences of epidemiology, genetics, morphology, distribution, clinical course, comorbidities, symptom-burden, and response to topical and systemic treatment of AD in adults compared with children. Recent epidemiologic studies have suggested that more children with AD have persistence in adulthood than previously reported, and there is also more adult-onset/recurrence of AD. We recently found distinct phenotypes and disease triggers in those with adult-onset AD. Adult AD has less of an association with FLG null mutations and has key immunologic differences compared with childhood AD. Recognition of these differences may improve the diagnosis and management of AD in adults.
ADA RESIDENT RESEARCH AWARDEE
Namita Jain, MD, MPH Promoting Early Detection of Melanoma during the Mammography Experience
Introduction: Invasive melanoma is the seventh most common cancer in women. Routine primary care mammography screening may serve as an opportunity to promote early detection of melanoma by increasing awareness and introducing skin self-examinations (SSE).
Methods: A pilot and feasibility study was designed to promote SSE in women receiving screening mammograms at Northwestern Medicine. The study entailed development of SSE materials, delivery of the educational program, and assessment of program effectiveness.
Results: Eighty-six percent of women with scheduled mammograms participated in the study (N=560). Among participants, 68% noticed the SSE information in the changing room. Of women who noticed the information, 78% thought the information was applicable, 68% identified with at least one risk factor for melanoma, and 20% checked her skin.
Discussion: Combining skin cancer screening with breast cancer screening is a novelty. A substantial proportion of women interviewed noticed the SSE information and identified with at least one risk factor for melanoma. Incorporating an educational intervention in the setting of screening mammography is a feasible way to increase awareness in a large proportion of at-risk women.
ADA 137 T H ANNUA L MEETIN G 23 JUL Y 1 9 - 23, 2017 Acknowledgements
The America Dermatological Association and the American Dermatological Association Research and Education Fund gratefully acknowledge the following members for their voluntary contributions during the past year.
Murad Alam W. Clark Lambert Rex Amonette Jack Lesher Eugene Bauer Stuart Lessin Timothy Berger Henry Lim Wilma Bergfeld James Maberry Brian Berman Howard Maibach Jeffrey Bernhard M. Peter Marinkovich Diane Berson Victor Marks Michael Bigby Lynn Mckinley-Grant Jean Bolognia Stanley Miller Karen Burke Alan Moshell Jeffey Callen Marianne O'Donoghue Valerie Callender Amy Paller John Carucci David Pariser Scott Collins Michael Piepkorn Ralph Daniel Adam Rubin Thomas Darling Thomas Russell Madeleine Duvic Robert Swerlick Alison Ehrlich Julian Trevino George Elgart Susan Walker Roselyn Epps Patricia Walker James Ertle Stephen Webster Richard Glogau Jonathan Weiss Maria Hordinsky Robert Weiss William James
ADA 137 T H ANNUA L MEETIN G 24 JUL Y 1 9 - 23, 2017
In Memoriam
Ronald Reisner, MD January, 2017
Allan Wirtzer, MD November, 2016
StefaniaJablonska, MD May, 2017
ADA 137 T H ANNUA L MEETIN G 25 JUL Y 1 9 - 23, 2017
MARK YOUR CALENDAR NOW FOR NEXT YEAR’S ANNUAL MEETING OF THE AMERICAN DERMATOLOGICAL ASSOCIATION
138th ANNUAL MEETING
October 7th-11th, 2018 Silverado Resort & Spa Napa Valley, California
See you there!
ADA 137 T H ANNUA L MEETIN G 26 JUL Y 1 9 - 23, 2017